Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift

Area of Science:

• Oncology
• Dermatology
• Immunotherapy

Background:

• Clinical stage III melanoma, characterized by resectable nodal disease and potential in-transit metastases, accounts for 15% of new diagnoses and recurrent cases.
• Current standard care involves surgical resection, adjuvant therapy, and radiation, yet high rates of regional recurrence and metastatic progression persist post-surgery.
• The success of immune checkpoint inhibitors in other settings has spurred interest in their neoadjuvant application for stage III melanoma.

Purpose of the Study:

• To explore the rationale behind using neoadjuvant immunotherapy for clinical stage III melanoma.
• To review significant clinical trials investigating neoadjuvant immunotherapy in this patient population.
• To discuss key aspects of neoadjuvant therapy, including response monitoring, surgical considerations, and future directions.

Main Methods:

• Review of existing literature and clinical trial data on neoadjuvant immunotherapy for stage III melanoma.
• Analysis of the immunological principles supporting neoadjuvant immune checkpoint inhibition.
• Discussion of surgical management and response assessment in the context of neoadjuvant treatment.

Main Results:

• Neoadjuvant immunotherapy is emerging as a potential paradigm shift in managing stage III melanoma.
• Clinical trials are evaluating the efficacy and safety of various immune checkpoint inhibitors in the preoperative setting.
• Understanding response patterns and optimizing surgical intervention are critical for successful neoadjuvant treatment.

Conclusions:

• Neoadjuvant immunotherapy presents a novel strategy to improve outcomes for patients with resectable stage III melanoma.
• Further research and clinical trials are necessary to define the optimal use of neoadjuvant therapies and address unanswered questions.
• This approach holds the potential to reduce recurrence rates and enhance survival in this challenging melanoma subset.